| Financial Year |
March 31 2023 |
| Monetary Funds |
214,449,906.69 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
25,651,326.59 |
| Accounts Receivable |
84,728,526.99 |
| Advances to Suppliers |
8,752,398.70 |
| Other Receivables |
414,594.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
405,692.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,717,297.47 |
| Total Current Assets |
346,119,743.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,262,786,675.87 |
| Under-construction Projects |
250,098,739.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
48,388,941.78 |
| R&D expenses |
-- |
| Goodwill |
3,530,484.46 |
| Long-Term Deferred and Prepaid Expenses |
21,029,782.30 |
| Deferred Income Tax Assets |
4,977,259.84 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,607,713,229.47 |
| Total Assets |
2,953,832,972.93 |
| Short-Term Loans |
285,678,843.07 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
144,221,206.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,834,411.82 |
| Taxes Payable |
4,458,245.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,708,202.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
151,423,237.11 |
| Other Current Liabilities |
4,524,762.24 |
| Sub-Total of Current Liabilities |
668,730,851.30 |
| Long-term Loans |
298,636,533.34 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,083.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
313,836,039.47 |
| Total Liabilities |
982,566,890.77 |
| Paid-In Capital(Or Share Stock) |
758,322,487.00 |
| Capital Surplus |
723,075,698.54 |
| Surplus Reserve |
139,960,301.05 |
| LESS:Treasury Stock |
75,149,726.17 |
| Undistributed Profits |
416,443,136.15 |
| Minority Stockholder's Interest |
8,614,185.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,962,651,896.57 |
| Owner's Equity（Stockholder's Equity） |
1,971,266,082.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,953,832,972.93 |
